INDUSTRY NOTES A biotech startup will team up with Merck to educate physicians about HIV drug-resistance testing. ViroLogic Inc. and Merck & Co. Inc. will jointly develop and execute educational programs on the utility of HIV drug-resistance testing for physicians across the nation. ViroLogic is a South San Francisco, Calif.-based biotechnology company specializing in developing treatments for serious viral, immunologic, and oncologic diseases. ViroLogic and Merck will conduct a series ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Health Care News and Ideas for Medical Conference Organizers, you'll get exclusive access to a large archive of premium content.

Already registered? here.